Browse Drug Recalls
65 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 65 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 65 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Sep 12, 2015 | MedroxyPROGESTERone/Lidocaine (150 mg/mL/1%) 10 mL Multi-Dose Vial, For IM In... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Cyclo/PE/Tropic/Ketor (1%/2.5%/1%/0.5%), 10 mL Opthalmic dropper bottle, For ... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Voriconazole Solution (1%(10 mg/mL), 15 mL dropper bottle; For Topical Ophtha... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Betamethasone SP, 2 mL (6 mg/mL),10 mL Multi-Dose Vial, For IM & Regional Inj... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Glycopyrrolate USP ( 1 mg/5 mL), 5 mL Single Use syringe, For IM or IV Injec... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Triamcinolone/Lidocaine (40 mg/1%/mL), 10 mL Multidose Vial, For IM & Regiona... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Cyclo/PE/Trop PF (1%/2.5%/1%), 3 mL dropper bottle, For topical ophthalmic us... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Triamcinolone diacetate USP (40 mg/mL), 30 mL Multi-Dose Vial, For IM & Regio... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Alprostadil (PGE-1), 5 mL (40 mcg/mL) in 10 mL Multi-Dose Vial, Rx only, Comp... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Dex Combo (Dexamethasone acetate 8mg/mL, dexamethasone sodium phosphate USP, ... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Phenylephrine 1.5%/ Lidocaine 1%, 1 mL Single Use Vial, For Intracameral Inje... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Tropicamide 0.5%/ Phenylephrine 5%, 2 mL Dropper Bottle For Topical Ophthalm... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | Morphine PF (2 mg/2 mL), 2 mL Single Use Vial, For IV or IM Administration, R... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| Sep 12, 2015 | HCG/B12 (5,000 units, 0.6 mg) 5 mL, Multi-Dose Vial, For IM or SC Injection, ... | Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within ex... | Class II | US Compounding Inc |
| May 16, 2014 | ePHEDrine Sulfate Injection, USP 25 mg/5 mL (5 mg/mL) Single Use 5 mL Syring... | Labeling: Label Error on Declared Strength; The outer light protective bags, where the ephedrine ... | Class II | US Compounding Inc |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.